JP Morgan Chase’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7K Sell
92,690
-336,213
-78% -$528K ﹤0.01% 6404
2025
Q4
$1.33M Buy
428,903
+234,534
+121% +$669K ﹤0.01% 4411
2025
Q3
$511K Buy
194,369
+103,922
+115% +$229K ﹤0.01% 5019
2025
Q2
$111K Buy
90,447
+74,825
+479% +$81.6K ﹤0.01% 5556
2025
Q1
$17.2K Buy
15,622
+10,484
+204% +$12.1K ﹤0.01% 6195
2024
Q4
$4.65K Buy
5,138
+4,444
+640% +$3.81K ﹤0.01% 6529
2024
Q3
$685 Hold
694
﹤0.01% 6770
2024
Q2
$625 Sell
694
-201,204
-100% -$151K ﹤0.01% 6665
2024
Q1
$238K Buy
+201,898
New +$222K ﹤0.01% 5252
2023
Q4
Sell
-43,583
Closed -$36.3K 7666
2023
Q3
$36.3K Buy
43,583
+39,627
+1,002% +$45.7K ﹤0.01% 5905
2023
Q2
$4.75K Sell
3,956
-115,677
-97% -$144K ﹤0.01% 6175
2023
Q1
$151K Sell
119,633
-797,936
-87% -$1.53M ﹤0.01% 5224
2022
Q4
$1.99M Buy
917,569
+844,868
+1,162% +$6.96M ﹤0.01% 3559
2022
Q3
$871K Buy
72,701
+13,697
+23% +$170K ﹤0.01% 4101
2022
Q2
$495K Sell
59,004
-51,309
-47% -$398K ﹤0.01% 4555
2022
Q1
$957K Buy
110,313
+64,083
+139% +$618K ﹤0.01% 4307
2021
Q4
$523K Buy
46,230
+3,685
+9% +$43.8K ﹤0.01% 4793
2021
Q3
$535K Buy
42,545
+1,932
+5% +$17.8K ﹤0.01% 4679
2021
Q2
$330K Buy
40,613
+6,666
+20% +$57.8K ﹤0.01% 4957
2021
Q1
$315K Buy
33,947
+6,465
+24% +$65.2K ﹤0.01% 4941
2020
Q4
$266K Buy
27,482
+4,360
+19% +$42.9K ﹤0.01% 4702
2020
Q3
$297K Buy
23,122
+6,368
+38% +$84.4K ﹤0.01% 4196
2020
Q2
$218K Buy
16,754
+2,615
+18% +$32.9K ﹤0.01% 4218
2020
Q1
$144K Buy
14,139
+213
+2% +$2.78K ﹤0.01% 4401
2019
Q4
$218K Sell
13,926
-133
-0.9% -$2.68K ﹤0.01% 4629
2019
Q3
$236K Buy
14,059
+8,064
+135% +$160K ﹤0.01% 4555
2019
Q2
$126K Buy
5,995
+2,798
+88% +$53.5K ﹤0.01% 4842
2019
Q1
$69K Buy
+3,197
New +$66.7K ﹤0.01% 5005

Other funds holding GOSS